|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 24/04/14 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 23/04/14 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 01/10/2023 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 01/04/2017 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/01/2015 | |
Haruhisa Inada
BRD | Director/Board Member | - | 30/04/2014 |
Shingo Torii
BRD | Director/Board Member | 73 | 01/05/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.86% | +1.75% | -12.84% | -30.02% | 235B | ||
| +0.22% | -2.47% | -10.71% | -46.89% | 47.13B | ||
| +1.88% | +0.56% | -42.33% | -55.12% | 40.56B | ||
| +3.68% | +3.98% | -40.42% | -51.73% | 21.03B | ||
| -0.64% | -0.71% | -30.45% | -63.11% | 16.6B | ||
| +4.18% | +2.31% | -45.21% | -66.64% | 15.87B | ||
| +0.73% | 0.00% | -6.47% | -54.70% | 12.09B | ||
| -1.40% | -6.23% | -2.02% | +33.68% | 9.86B | ||
| +1.18% | -2.27% | -10.42% | -23.89% | 8.45B | ||
| Average | +1.30% | -1.09% | -22.32% | -39.83% | 45.14B | |
| Weighted average by Cap. | +1.63% | -0.13% | -18.44% | -37.45% |
- Stock Market
- Stocks
- Stock
- Stock
Select your edition
All financial news and data tailored to specific country editions
















